{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:38:45Z","timestamp":1790131125602,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770824"],"award-info":[{"award-number":["81770824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270239"],"award-info":[{"award-number":["81270239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Abnormal myocardial Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5 expression and function cause lethal ventricular arrhythmias during myocardial ischemia\u2013reperfusion (I\/R). Protein inhibitor of activated STAT Y (PIASy)-mediated caveolin-3 (Cav-3) SUMO modification affects Cav-3 binding to the voltage-gated sodium channel 1.5 (Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5). PIASy activity is increased after myocardial I\/R, but it is unclear whether this is attributable to plasma membrane Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5 downregulation and ventricular arrhythmias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using recombinant adeno-associated virus subtype 9 (AAV9), rat cardiac\n                      <jats:italic>PIASy<\/jats:italic>\n                      was silenced using intraventricular injection of\n                      <jats:italic>PIASy<\/jats:italic>\n                      short hairpin RNA (shRNA). After two weeks, rat hearts were subjected to I\/R and electrocardiography was performed to assess malignant arrhythmias. Tissues from peri-infarct areas of the left ventricle were collected for molecular biological measurements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PIASy was upregulated by I\/R (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), with increased SUMO2\/3 modification of Cav-3 and reduced membrane Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5 density (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). AAV9-\n                      <jats:italic>PIASy<\/jats:italic>\n                      shRNA intraventricular injection into the rat heart downregulated PIASy after I\/R, at both mRNA and protein levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 vs. Scramble-shRNA\u2009+\u2009I\/R group), decreased SUMO-modified Cav-3 levels, enhanced Cav-3 binding to Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5, and prevented I\/R-induced decrease of Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5 and Cav-3 co-localization in the intercalated disc and lateral membrane.\n                      <jats:italic>PIASy<\/jats:italic>\n                      silencing in rat hearts reduced I\/R-induced fatal arrhythmias, which was reflected by a modest decrease in the duration of ventricular fibrillation (VF;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 vs. Scramble-shRNA\u2009+\u2009I\/R group) and a significantly reduced arrhythmia score (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01 vs. Scramble-shRNA\u2009+\u2009I\/R group). The anti-arrhythmic effects of\n                      <jats:italic>PIASy<\/jats:italic>\n                      silencing were also evidenced by decreased episodes of ventricular tachycardia (VT), sustained VT and VF, especially at the time 5\u201310\u00a0min after ischemia (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 vs. Scramble-shRNA\u2009+\u2009IR group). Using in vitro human embryonic kidney 293\u00a0T (HEK293T) cells\u00a0and isolated adult rat cardiomyocyte models exposed to hypoxia\/reoxygenation (H\/R), we confirmed that increased PIASy promoted Cav-3 modification by SUMO2\/3 and Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5\/Cav-3 dissociation after H\/R. Mutation of SUMO consensus lysine sites in Cav-3 (K38R or K144R) altered the membrane expression levels of Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5 and Cav-3 before and after H\/R in HEK293T cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      I\/R-induced cardiac PIASy activation increased Cav-3 SUMOylation by SUMO2\/3 and dysregulated Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5-related ventricular arrhythmias. Cardiac-targeted\n                      <jats:italic>PIASy<\/jats:italic>\n                      silencing mediated Cav-3 deSUMOylation and partially prevented I\/R-induced Na\n                      <jats:sub>v<\/jats:sub>\n                      1.5 downregulation in the plasma membrane of cardiomyocytes, and subsequent ventricular arrhythmias in rats. PIASy was identified as a potential therapeutic target for life-threatening arrhythmias in patients with ischemic heart diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40779-022-00415-x","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T20:02:17Z","timestamp":1665691337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia\/reperfusion-induced Nav1.5 downregulation and ventricular arrhythmias"],"prefix":"10.1016","volume":"9","author":[{"given":"Chen-Chen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Kun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-Fang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Long","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-9507","authenticated-orcid":false,"given":"Wei-Ke","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"415_CR1","doi-asserted-by":"publisher","first-page":"609733","DOI":"10.3389\/fphys.2020.609733","volume":"11","author":"C Dong","year":"2020","unstructured":"Dong C, Wang Y, Ma A, Wang T. Life cycle of the cardiac voltage-gated sodium channel Nav1.5. Front Physiol. 2020;11:609733.","journal-title":"Front Physiol"},{"issue":"1","key":"415_CR2","doi-asserted-by":"publisher","first-page":"e202012722","DOI":"10.1085\/jgp.202012722","volume":"153","author":"S Nathan","year":"2021","unstructured":"Nathan S, Gabelli SB, Yoder JB, Srinivasan L, Aldrich RW, Tomaselli GF, et al. Structural basis of cytoplasmic NaV1.5 and NaV1.4 regulation. J Gen Physiol. 2021;153(1):e202012722.","journal-title":"J Gen Physiol"},{"issue":"4","key":"415_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/cells11040665","volume":"11","author":"RM El","year":"2022","unstructured":"El RM, Coles S, Musa H, Stevens TL, Wallace MJ, Murphy NP, et al. Altered expression of zonula occludens-1 affects cardiac Na+ channels and increases susceptibility to ventricular arrhythmias. Cells. 2022;11(4):665.","journal-title":"Cells"},{"issue":"7 Pt B","key":"415_CR4","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.bbamcr.2016.02.014","volume":"1863","author":"E Zaklyazminskaya","year":"2016","unstructured":"Zaklyazminskaya E, Dzemeshkevich S. The role of mutations in the SCN5A gene in cardiomyopathies. Biochim Biophys Acta. 2016;1863(7 Pt B):1799\u2013805.","journal-title":"Biochim Biophys Acta"},{"key":"415_CR5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52373","volume":"9","author":"HQ Yang","year":"2020","unstructured":"Yang HQ, Perez-Hernandez M, Sanchez-Alonso J, Shevchuk A, Gorelik J, Rothenberg E, et al. Ankyrin-G mediates targeting of both Na+ and KATP channels to the rat cardiac intercalated disc. Elife. 2020;9:e52373.","journal-title":"Elife"},{"issue":"52","key":"415_CR6","doi-asserted-by":"publisher","first-page":"18148","DOI":"10.1074\/jbc.RA120.015216","volume":"295","author":"NN Turan","year":"2020","unstructured":"Turan NN, Moshal KS, Roder K, Baggett BC, Kabakov AY, Dhakal S, et al. The endosomal trafficking regulator LITAF controls the cardiac Nav1.5 channel via the ubiquitin ligase NEDD4\u20132. J Biol Chem. 2020;295(52):18148\u201359.","journal-title":"J Biol Chem"},{"key":"415_CR7","doi-asserted-by":"publisher","first-page":"21538","DOI":"10.1038\/srep21538","volume":"6","author":"J Zhou","year":"2016","unstructured":"Zhou J, Wang L, Zuo M, Wang X, Ahmed AS, Chen Q, et al. Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm. Sci Rep. 2016;6:21538.","journal-title":"Sci Rep"},{"issue":"2","key":"415_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/cvr\/cvw009","volume":"110","author":"M Matamoros","year":"2016","unstructured":"Matamoros M, Perez-Hernandez M, Guerrero-Serna G, Amoros I, Barana A, Nunez M, et al. Nav1.5 N-terminal domain binding to alpha1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels. Cardiovasc Res. 2016;110(2):279\u201390.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"415_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCRESAHA.116.309254","volume":"119","author":"CA Eichel","year":"2016","unstructured":"Eichel CA, Beuriot A, Chevalier MY, Rougier JS, Louault F, Dilanian G, et al. Lateral membrane-specific MAGUK CASK down-regulates NaV1.5 channel in cardiac myocytes. Circ Res. 2016;119(4):544\u201356.","journal-title":"Circ Res"},{"key":"415_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/164_2017_45","volume":"246","author":"E Balse","year":"2018","unstructured":"Balse E, Eichel C. The cardiac sodium channel and its protein partners. Handb Exp Pharmacol. 2018;246:73\u201399.","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"415_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00395-016-0542-9","volume":"111","author":"JM Schilling","year":"2016","unstructured":"Schilling JM, Horikawa YT, Zemljic-Harpf AE, Vincent KP, Tyan L, Yu JK, et al. Electrophysiology and metabolism of caveolin-3-overexpressing mice. Basic Res Cardiol. 2016;111(3):28.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"415_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00022.2021","volume":"102","author":"RE Dixon","year":"2022","unstructured":"Dixon RE, Navedo MF, Binder MD, Santana LF. Mechanisms and physiological implications of cooperative gating of clustered ion channels. Physiol Rev. 2022;102(3):1159\u2013210.","journal-title":"Physiol Rev"},{"key":"415_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.yjmcc.2013.03.013","volume":"61","author":"J Cheng","year":"2013","unstructured":"Cheng J, Valdivia CR, Vaidyanathan R, Balijepalli RC, Ackerman MJ, Makielski JC. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A. J Mol Cell Cardiol. 2013;61:102\u201310.","journal-title":"J Mol Cell Cardiol"},{"issue":"20","key":"415_CR14","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.106.635268","volume":"114","author":"M Vatta","year":"2006","unstructured":"Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation. 2006;114(20):2104\u201312.","journal-title":"Circulation"},{"issue":"2","key":"415_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/BJ20100158","volume":"428","author":"KA Wilkinson","year":"2010","unstructured":"Wilkinson KA, Henley JM. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J. 2010;428(2):133\u201345.","journal-title":"Biochem J"},{"issue":"5","key":"415_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/cells11050814","volume":"11","author":"U Sahin","year":"2022","unstructured":"Sahin U, de The H, Lallemand-Breitenbach V. Sumoylation in physiology, pathology and therapy. Cells. 2022;11(5):814.","journal-title":"Cells"},{"issue":"17","key":"415_CR17","doi-asserted-by":"publisher","first-page":"14830","DOI":"10.1074\/jbc.M110.214270","volume":"286","author":"SR Fuhs","year":"2011","unstructured":"Fuhs SR, Insel PA. Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization. J Biol Chem. 2011;286(17):14830\u201341.","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"415_CR18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1042\/BST0351405","volume":"35","author":"JJ Palvimo","year":"2007","unstructured":"Palvimo JJ. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem Soc Trans. 2007;35(Pt 6):1405\u20138.","journal-title":"Biochem Soc Trans"},{"key":"415_CR19","doi-asserted-by":"publisher","first-page":"8979","DOI":"10.1038\/ncomms9979","volume":"6","author":"Y Yan","year":"2015","unstructured":"Yan Y, Ollila S, Wong I, Vallenius T, Palvimo JJ, Vaahtomeri K, et al. SUMOylation of AMPKalpha1 by PIAS4 specifically regulates mTORC1 signalling. Nat Commun. 2015;6:8979.","journal-title":"Nat Commun"},{"issue":"6","key":"415_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066947","volume":"8","author":"R Diezko","year":"2013","unstructured":"Diezko R, Suske G. Ligand binding reduces SUMOylation of the peroxisome proliferator-activated receptor gamma (PPARgamma) activation function 1 (AF1) domain. PLoS One. 2013;8(6):e66947.","journal-title":"PLoS ONE"},{"issue":"4","key":"415_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/FJC.0000000000000412","volume":"68","author":"X Wei","year":"2016","unstructured":"Wei X, Zhu A, Zhang Y, Yao S, Mao W. Pre- and delayed treatments with ranolazine ameliorate ventricular arrhythmias and Nav1.5 downregulation in ischemic\/reperfused rat hearts. J Cardiovasc Pharmacol. 2016;68(4):269\u201379.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"415_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.yjmcc.2011.06.012","volume":"51","author":"WE Louch","year":"2011","unstructured":"Louch WE, Sheehan KA, Wolska BM. Methods in cardiomyocyte isolation, culture, and gene transfer. J Mol Cell Cardiol. 2011;51(3):288\u201398.","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"415_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075894","volume":"8","author":"BA Piras","year":"2013","unstructured":"Piras BA, O\u2019Connor DM, French BA. Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver. PLoS One. 2013;8(9):e75894.","journal-title":"PLoS ONE"},{"issue":"2","key":"415_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/jcm8020212","volume":"8","author":"E Bacchelli","year":"2019","unstructured":"Bacchelli E, Loi E, Cameli C, Moi L, Vega-Benedetti AF, Blois S, et al. Analysis of a sardinian multiplex family with autism spectrum disorder points to post-synaptic density gene variants and identifies CAPG as a functionally relevant candidate gene. J Clin Med. 2019;8(2):212.","journal-title":"J Clin Med"},{"key":"415_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103068","volume":"61","author":"M Wei","year":"2020","unstructured":"Wei M, Ma Y, Shen L, Xu Y, Liu L, Bu X, et al. NDRG2 regulates adherens junction integrity to restrict colitis and tumourigenesis. EBioMedicine. 2020;61:103068.","journal-title":"EBioMedicine"},{"issue":"9","key":"415_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/cvr\/22.9.656","volume":"22","author":"MJ Curtis","year":"1988","unstructured":"Curtis MJ, Walker MJ. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res. 1988;22(9):656\u201365.","journal-title":"Cardiovasc Res"},{"issue":"17","key":"415_CR27","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.3390\/cancers13174402","volume":"13","author":"A Kukkula","year":"2021","unstructured":"Kukkula A, Ojala VK, Mendez LM, Sistonen L, Elenius K, Sundvall M. Therapeutic potential of targeting the SUMO pathway in cancer. Cancers (Basel). 2021;13(17):4402.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"415_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/gt.2014.7","volume":"21","author":"AH Chaanine","year":"2014","unstructured":"Chaanine AH, Nonnenmacher M, Kohlbrenner E, Jin D, Kovacic JC, Akar FG, et al. Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure. Gene Ther. 2014;21(4):379\u201386.","journal-title":"Gene Ther"},{"issue":"2","key":"415_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCRESAHA.118.313811","volume":"124","author":"L Ni","year":"2019","unstructured":"Ni L, Scott LJ, Campbell HM, Pan X, Alsina KM, Reynolds J, et al. Atrial-specific gene delivery using an adeno-associated viral vector. Circ Res. 2019;124(2):256\u201362.","journal-title":"Circ Res"},{"issue":"4","key":"415_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-016-0561-6","volume":"111","author":"Y Yang","year":"2016","unstructured":"Yang Y, Ma Z, Hu W, Wang D, Jiang S, Fan C, et al. Caveolin-1\/-3: therapeutic targets for myocardial ischemia\/reperfusion injury. Basic Res Cardiol. 2016;111(4):45.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"415_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/FJC.0000000000000454","volume":"69","author":"A Zhu","year":"2017","unstructured":"Zhu A, Wei X, Zhang Y, You T, Yao S, Yuan S, et al. Propofol provides cardiac protection by suppressing the proteasome degradation of Caveolin-3 in ischemic\/reperfused rat hearts. J Cardiovasc Pharmacol. 2017;69(3):170\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"key":"415_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3389\/fphys.2018.01548","volume":"9","author":"R Vaidyanathan","year":"2018","unstructured":"Vaidyanathan R, Reilly L, Eckhardt LL. Caveolin-3 microdomain: arrhythmia implications for potassium inward rectifier and cardiac sodium channel. Front Physiol. 2018;9:1548.","journal-title":"Front Physiol"},{"issue":"4","key":"415_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/cvr\/cvr142","volume":"91","author":"S Marangoni","year":"2011","unstructured":"Marangoni S, Di Resta C, Rocchetti M, Barile L, Rizzetto R, Summa A, et al. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization. Cardiovasc Res. 2011;91(4):606\u201316.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"415_CR34","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.3390\/ijms22105391","volume":"22","author":"YC Chang","year":"2021","unstructured":"Chang YC, Oram MK, Bielinsky AK. SUMO-targeted ubiquitin ligases and their functions in maintaining genome stability. Int J Mol Sci. 2021;22(10):5391.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"415_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009720","volume":"5","author":"Q Cai","year":"2010","unstructured":"Cai Q, Verma SC, Kumar P, Ma M, Robertson ES. Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS One. 2010;5(3):e9720.","journal-title":"PLoS ONE"},{"issue":"9","key":"415_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ncb1458","volume":"8","author":"AM Mabb","year":"2006","unstructured":"Mabb AM, Wuerzberger-Davis SM, Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol. 2006;8(9):986\u201393.","journal-title":"Nat Cell Biol"},{"key":"415_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.795747","volume":"8","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu Z, Chen H, Huang X, Huang X, Lei Y, et al. p53 SUMOylation mediates aopp-induced endothelial senescence and apoptosis evasion. Front Cardiovasc Med. 2021;8:795747.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"415_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.123","volume":"3","author":"Y Han","year":"2022","unstructured":"Han Y, Huang X, Cao X, Li Y, Gao L, Jia J, et al. SENP3-mediated TIP60 deSUMOylation is required for DNA-PKcs activity and DNA damage repair. MedComm. 2022;3(2):e123.","journal-title":"MedComm"},{"issue":"7","key":"415_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/CIRCULATIONAHA.114.015218","volume":"132","author":"P Glynn","year":"2015","unstructured":"Glynn P, Musa H, Wu X, Unudurthi SD, Little S, Qian L, et al. Voltage-gated sodium channel phosphorylation at ser571 regulates late current, arrhythmia, and cardiac function in vivo. Circulation. 2015;132(7):567\u201377.","journal-title":"Circulation"},{"issue":"3","key":"415_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13210","volume":"225","author":"SM Iqbal","year":"2019","unstructured":"Iqbal SM, Lemmens-Gruber R. Phosphorylation of cardiac voltage-gated sodium channel: Potential players with multiple dimensions. Acta Physiol (Oxf). 2019;225(3):e13210.","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"415_CR41","doi-asserted-by":"publisher","first-page":"H782","DOI":"10.1152\/ajpheart.00817.2010","volume":"302","author":"H Hallaq","year":"2012","unstructured":"Hallaq H, Wang DW, Kunic JD, George AJ, Wells KS, Murray KT. Activation of protein kinase C alters the intracellular distribution and mobility of cardiac Na+ channels. Am J Physiol Heart Circ Physiol. 2012;302(3):H782\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"415_CR42","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/jcmm.12588","volume":"19","author":"C Zhao","year":"2015","unstructured":"Zhao C, Wang L, Ma X, Zhu W, Yao L, Cui Y, et al. Cardiac Nav1.5 is modulated by ubiquitin protein ligase E3 component n-recognin UBR3 and 6. J Cell Mol Med. 2015;19(9):2143\u201352.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"415_CR43","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/ijms23031381","volume":"23","author":"H Daimi","year":"2022","unstructured":"Daimi H, Lozano-Velasco E, Aranega A, Franco D. Genomic and non-genomic regulatory mechanisms of the cardiac sodium channel in cardiac arrhythmias. Int J Mol Sci. 2022;23(3):1381.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"415_CR44","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1113\/JP282768","volume":"600","author":"MA Fouda","year":"2022","unstructured":"Fouda MA, Ghovanloo MR, Ruben PC. Late sodium current: incomplete inactivation triggers seizures, myotonias, arrhythmias, and pain syndromes. J Physiol. 2022;600(12):2835\u201351.","journal-title":"J Physiol"},{"issue":"1","key":"415_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1124\/jpet.106.101832","volume":"318","author":"Y Song","year":"2006","unstructured":"Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther. 2006;318(1):214\u201322.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-022-00415-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-022-00415-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-022-00415-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:52:45Z","timestamp":1772830365000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-022-00415-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1186\/s40779-022-00415-x","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"11 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Use and Care Committee at Tongji Medical College, Huazhong University of Science and Technology ([2022] IACUC Number: 2853).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}